At a glance
ClinicalIndex Comparison Record- ✓Diagnosed with Bipolar I Disorder
- ✓Age 18-65 years
- ✓Recently discharged from or receiving outpatient care at Saint John of God Clinic in La Ceja
- ✓Living in Medellin or eastern municipalities of Antioquia department
- ✕First episode of mania
- ✕Bipolar II disorder, schizoaffective disorder, or other bipolar spectrum disorders
- ✕Personality disorders mimicking bipolar disorder or sociopathic disorder
- ✕Epilepsy
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect of Pharmaceutical Care in Patients With Bipolar I Disorder at St John of God Clinic. Randomized Trial.
In Brief
A clinical study evaluating Pharmaceutical Care and Education for Bipolar Disorder. Completed, enrolled 92 participants across 1 site.
Detailed Summary
This project aims, through pharmaceutical care in patients with Bipolar I Disorder, improve compliance and adherence rate, associated with greater effectiveness and safety of drug therapy to help achieve therapeutic goals, and finally to improving the quality of life of patients.
Study Details
Timeline
Interventions
Pharmaceutical care will be provided according to Dader Method for pharmaceutical care and will be carried out in collaboration with patients and physicians.The time between admission to the group and 20 days,the pharmacist will enhance the information related to treatment adherence and investigate by criteria to make an approach to the effectiveness and safety of treatment, through phone calls(weeks 1,3, 4-6) and a home visit(week 2). Pharmacist will call the patient weekly in order to increase adherence. At each appointment will assess of parameters of efficacy; Depression and Mania Rating Scale, Clinical Global Assessment Scale, Quality of life and adherence to treatment
The control group will receive the usual care and verbal and written information and education about mental health and bipolar disorder for patients and their families. The written material is a brochure designed for this purpose, which focused on the goals and importance of adherence with pharmacological and nonpharmacological interventions to achieve treatment goals. Patients met again with the pharmacist every three months during one year. At each appointment will assess of parameters of efficacy and safety. Quality of life (Sf - 36 test), adherence to treatment, the severity of depressive symptoms in individuals, Symptoms of Mania, the psychiatrist rated patient impairment.